
Slow and steady uptake of genAI in APAC healthcare in 2024
Generative AI has been well-received in the healthcare industry, offering potential for efficiency and improvement in patient care. Japanese partners are interested in using genAI platforms, while in the US, adoption is slower due to insurance and reimbursement considerations. Regulatory and cultural barriers will also impact adoption, with privacy and patient rights being major concerns….